Status:

UNKNOWN

Low-dose Lenalidomide for Non-severe COVID-19 Treatment Trial

Lead Sponsor:

Hospital Universitario Getafe

Conditions:

COVID-19

Eligibility:

All Genders

60+ years

Phase:

PHASE4

Brief Summary

Double-blind randomized controlled clinical trial (RCT) of low-dose lenalidomide in the treatment of elderly patients (\> 60 years of age) with mild to moderate clinical signs of COVID-19 disease from...

Eligibility Criteria

Inclusion

  • Subjects \> 60 years of age
  • Diagnosed case (PCR test for COVID-19 if available) or COVID-19 clinical symptoms (defined as fever, dry cough, dyspnea, chest radiography with compatible findings with COVID-19)
  • Lymphocyte count ≥ 0.2 x 103/µL and ≤1.0 x 103/µL.
  • Neutrophil count ≥ 1.8 x 103/µL, platelets ≥ 150 x 103/µL.
  • ROX ≥ 10 index
  • Signed informed consent document
  • Willing to comply with the lenalidomide Risk Minimization Program (Pregnancy Prevention Program approved)

Exclusion

  • Absolute contraindication of lenalidomide use or hypersensitivity to the active ingredient or any of the excipients.
  • Active neoplasia
  • Previous autoimmune disease
  • Concurrent infection of HBV, HCV or tuberculosis.
  • Aspartate transaminase (AST) or alanine transaminase (ALT) \> 3 times the upper limit of normal (ULN).
  • Bilirubin levels \> 1.5 times the ULN
  • Renal impairment with an estimated GF \< 30ml/min
  • Venous thromboembolism events within the previous 3 years
  • Significant active heart disease within the previous 6 months, including congestive heart failure (class II-IV NYHA), unstable angina or myocardial infarctions
  • Sexually active subjects who refuse the lenalidomide Risk Minimization Program
  • Inability to comply with the working protocol under the responsible health professional opinion.

Key Trial Info

Start Date :

October 27 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2021

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT04361643

Start Date

October 27 2020

End Date

December 31 2021

Last Update

July 31 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital Universitario de Getafe

Getafe, Spain, 28905